Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2021-02-11 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Neuland Laboratories Limited addressed to BSE Limited and the National Stock Exchange of India. It is a response to a request for clarification regarding significant price movement of the company's shares. The letter states that the company has complied with disclosure regulations and that the share price movement is market driven. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is a regulatory communication clarifying a market event, fitting the description of a general regulatory announcement or compliance document. Therefore, it best fits the category of Regulatory Filings (RNS). The document length is short (1902 characters), and it is not a report or announcement of a report publication, so it is not RPA. It is not a certification letter either, but a regulatory clarification letter.
2021-02-11 English
Copy of Newspaper Publication
Earnings Release Classification · 95% confidence The document is a compliance filing addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter ended December 31, 2020. It includes an extract of consolidated unaudited financial results with key financial figures such as revenue, net profit before and after tax, and earnings per share. The document mentions that the financial results have been reviewed by the Audit Committee and approved by the Board of Directors. The filing references Regulation 47(1)(b) of the SEBI Listing Regulations, 2015, which pertains to the publication of financial results. The document is not a full annual or quarterly report but rather a public announcement of the unaudited financial results. Given the nature of the document as a formal announcement of financial results for a quarter, it fits the definition of an Earnings Release (ER). The document length (15,000 characters) and content support that it is more than a brief notice but does not contain the full detailed financial statements and analysis typical of an Interim/Quarterly Report (IR). Therefore, the best classification is Earnings Release (ER). Q3 2021
2021-02-03 English
Investor Presentation
Interim / Quarterly Report Classification · 100% confidence The document contains a detailed financial statement titled 'Statement of Standalone Financial Results for the Quarter and Nine Months Ended 31 December 2020' along with an Independent Auditor's Review Report. It references Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results. The presence of unaudited standalone and consolidated financial results for a quarter and nine months, along with auditor's limited review, indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-02-02 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a communication from Neuland Laboratories Limited to stock exchanges regarding the outcome of a Board Meeting where unaudited standalone and consolidated financial results for the quarter ended December 31, 2020, were approved. It includes the financial results themselves, a limited review report by the statutory auditors, and a press release with an investor presentation. The presence of detailed financial data for the quarter and nine months ended December 31, 2020, along with auditor's review, indicates this is a quarterly financial report. The document is about unaudited quarterly financial results, which fits the definition of an Interim / Quarterly Report (IR). It is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. Q3 2021
2021-02-02 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a communication from Neuland Laboratories Limited to stock exchanges regarding the outcome of a Board Meeting where unaudited standalone and consolidated financial results for the quarter ended December 31, 2020, were approved. It includes the financial results themselves, a limited review report by the statutory auditors, and a press release with an investor presentation. The presence of detailed financial data for the quarter and nine months ended December 31, 2020, and the auditor's review report indicates this is a comprehensive interim financial report. The document is about quarterly unaudited financial results, which fits the definition of an Interim / Quarterly Report (IR). It is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. Q3 2021
2021-02-02 English
Financial Result Updates
Regulatory Filings
2021-02-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.